1. Non-peptidic guanidinium-functionalized silica nanoparticles as selective mitochondria-targeting drug nanocarriers;Ahn;J. Mater. Chem. B,2018
2. Akkın, S.,Varan, G.,Aksüt D.,Malanga, M.,Ercan, A.,Şe,n M., Bilensoy, E., 2022. “A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU” International Journal of Pharmaceutics, Volume 623, doi: doi: 10.1016/j.ijpharm.2022.121940.
3. American Cancer Society, 2020 https://www.cancer.org/cancer/types/lymphoma.html Last access date: 21 march 2024.
4. Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin’s lymphoma;Ansell;Leukemia,2004
5. Cationic nanoparticles for cancer therapy;Bilensoy;Expert Opin Drug Deliv.,2010